Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
Holding ERNA?
Track your performance easily

Eterna Therapeutics (ERNA) Cash flow

215 Followers

Eterna Therapeutics Cash Flow

ERNA's free cash flow for Q was $-2.55M. For the fiscal year, ERNA's free cash flow was decreased by $554.00K and operating cash flow was $-2.30M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -16.53M$ -20.41M$ -20.98M$ -23.49M$ -8.10M
Investing Cash Flow
$ -365.00K$ -19.00K$ -47.00K$ -22.74M$ -39.00K
Financing Cash Flow
$ 17.61M$ 16.56M$ 19.58M$ 61.59M$ 4.67M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 36.21M$ 11.67M$ 15.54M$ 16.98M$ 1.63M
Income Tax Paid Supplemental Data
$ 2.00K$ 4.00K$ 15.00K$ 1.00K$ 26.00K
Interest Paid Supplemental Data
$ 13.00K$ 20.00K$ 30.00K$ 225.00K$ 96.00K
Issuance Of Capital Stock
--$ 19.71M$ 52.02M-
Issuance Of Debt
$ 17.91M$ 16.50M$ -2.00K$ -410.00K$ 310.00K
Repayment Of Debt
$ -1.50M$ -1.50M$ -2.00K$ -410.00K$ -2.77M
Free Cash Flow
$ -16.89M$ -20.42M$ -20.97M$ -23.50M$ -8.14M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Eterna Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis